ES2113845T3 - Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos. - Google Patents

Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos.

Info

Publication number
ES2113845T3
ES2113845T3 ES88307750T ES88307750T ES2113845T3 ES 2113845 T3 ES2113845 T3 ES 2113845T3 ES 88307750 T ES88307750 T ES 88307750T ES 88307750 T ES88307750 T ES 88307750T ES 2113845 T3 ES2113845 T3 ES 2113845T3
Authority
ES
Spain
Prior art keywords
difluoronucleosides
preparation
deoxy
procedure
erythro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88307750T
Other languages
English (en)
Inventor
Ta-Sen Chou
Perry Clark Heath
Lawrence Edward Patterson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2113845T3 publication Critical patent/ES2113845T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)

Abstract

LA PRESENTE INVENCION DESCRIBE UN PROCESO PARA LA PREPARACION DE LACTAMAS INTERMEDIAS EN LA PRODUCCION DE 2,''2''DIFLUORONUCLEOSIDOS DE FORMA QUE QUEDE SUSTANCIALMENTE REDUCIDA REVERSION HACIA LA FORMA LACTONA DE CADENA ABIERTA, Y EL ENANTIOMERO ERITRO DESEADO PUEDE SER AISLADO SELECTIVAMENTE A PARTIR DE UNA MEZCLA ENANTIOMERICA DE ERITRO Y TREOLACTONAS EN FORMA CRISTALINA. TAMBIEN SE DESCRIBE UN PROCESO PARA LA PRODUCCION DE 2''- DEOXI - 2'',2''- DIFLUORONUCLEOSIDOS EN UNA RELACION ANOMERICA ALFA/BETA APROXIMADA DE 1:1, ASI COMO PROCESOS PARA AISLAR SELECTIVAMENTE BETA - 2''- DEOXI 2''2''-DIFLUOROCITIDINA, UNA SAL DE ADICION DE UN ACIDO ORGANICO O INORGANICO DERIVADO DE ESTA, A PARTIR DE UNA MEZCLA ALFA/BETA 1:1.
ES88307750T 1987-08-28 1988-08-22 Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos. Expired - Lifetime ES2113845T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9072587A 1987-08-28 1987-08-28

Publications (1)

Publication Number Publication Date
ES2113845T3 true ES2113845T3 (es) 1998-05-16

Family

ID=22224017

Family Applications (4)

Application Number Title Priority Date Filing Date
ES95201846T Expired - Lifetime ES2157289T3 (es) 1987-08-28 1988-08-22 Procedimiento para la preparacion de 2'-desoxi-2',2'-difluoronucleosidos.
ES88307750T Expired - Lifetime ES2113845T3 (es) 1987-08-28 1988-08-22 Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos.
ES95201845T Expired - Lifetime ES2176279T3 (es) 1987-08-28 1988-08-22 Procedimiento estereoselectivo para preparar 2`-2`-difluorolactonen protegidos.
ES94202041T Expired - Lifetime ES2131152T3 (es) 1987-08-28 1988-08-22 Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES95201846T Expired - Lifetime ES2157289T3 (es) 1987-08-28 1988-08-22 Procedimiento para la preparacion de 2'-desoxi-2',2'-difluoronucleosidos.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES95201845T Expired - Lifetime ES2176279T3 (es) 1987-08-28 1988-08-22 Procedimiento estereoselectivo para preparar 2`-2`-difluorolactonen protegidos.
ES94202041T Expired - Lifetime ES2131152T3 (es) 1987-08-28 1988-08-22 Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales.

Country Status (11)

Country Link
EP (4) EP0688782B1 (es)
JP (5) JP2738540B2 (es)
KR (1) KR970002659B1 (es)
AT (4) ATE202113T1 (es)
CA (1) CA1324128C (es)
DE (4) DE3856158T2 (es)
ES (4) ES2157289T3 (es)
GR (1) GR3026611T3 (es)
HU (3) HU202249B (es)
IE (1) IE81131B1 (es)
IL (1) IL87517A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2012129A1 (en) * 1989-03-20 1990-09-20 Ramakrishnan Nagarajan Recovery of difluoro sugar
US5256797A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for separating 2-deoxy-2,2-difluoro-D-ribofuranosyl alkylsulfonate anomers
US5401861A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Low temperature process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5252756A (en) * 1992-06-22 1993-10-12 Eli Lilly And Company Process for preparing beta-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl-arylsulfonates
UA41261C2 (uk) * 1992-06-22 2001-09-17 Елі Ліллі Енд Компані Спосіб одержання збагачених бета-аномером нуклеозидів
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
JP2000501738A (ja) 1995-12-13 2000-02-15 イーライ・リリー・アンド・カンパニー α，α―ジフルオロ―β―ヒドロキシチオールエステル及びその合成
KR100578616B1 (ko) * 2004-07-23 2006-05-10 한미약품 주식회사 Ｄ-에리트로-2,2-다이플루오로-2-데옥시-1-옥소라이보스화합물의 제조방법
EP1940859A1 (en) * 2005-10-28 2008-07-09 Arch Pharmalabs Limited An improved process for preparation of gemcitabine hydrochloride
KR101259648B1 (ko) * 2005-12-14 2013-05-09 동아에스티 주식회사 2′,2′-디플루오로뉴클레오시드 및 중간체의 새로운 제조방법
KR100741310B1 (ko) * 2006-08-01 2007-08-01 (주) 유일팜테크 젬시타빈의 합성에 유용한 신규한나프탈렌-2-카르복실레이트 유도체와 그의 제조방법
EP2139884B1 (en) * 2007-03-23 2013-12-04 Dongwoo Syntech Co., Ltd. Process for preparing of 2'-deoxy-2'2'-difluorocytidine
JP2011524369A (ja) 2008-06-12 2011-09-01 サイノファーム タイワン リミテッド ゲムシタビン塩基の結晶多形
GB0812895D0 (en) 2008-07-15 2008-08-20 Glycom As Crystalline carbohydrate derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
EP0184365B1 (en) * 1984-12-04 1993-08-04 Eli Lilly And Company Improvements in the treatment of tumors in mammals
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents

Also Published As

Publication number Publication date
IE882608L (en) 1989-02-28
DE3856158T2 (de) 1998-08-20
KR890003794A (ko) 1989-04-18
DE3856158D1 (de) 1998-05-14
ES2176279T3 (es) 2002-12-01
HU9201768D0 (en) 1992-08-28
JPH1081696A (ja) 1998-03-31
KR970002659B1 (ko) 1997-03-07
EP0630905B1 (en) 1999-05-06
CA1324128C (en) 1993-11-09
EP0688782A1 (en) 1995-12-27
EP0630905A1 (en) 1994-12-28
JP2738540B2 (ja) 1998-04-08
DE3856330D1 (de) 1999-06-10
JP2810034B2 (ja) 1998-10-15
EP0306190B1 (en) 1998-04-08
IL87517A (en) 1993-05-13
HUT47590A (en) 1989-03-28
JP2899576B2 (ja) 1999-06-02
ES2131152T3 (es) 1999-07-16
ATE202113T1 (de) 2001-06-15
GR3026611T3 (en) 1998-07-31
HU202249B (en) 1991-02-28
ATE164847T1 (de) 1998-04-15
IE81131B1 (en) 2000-03-22
EP0688783B1 (en) 2001-06-13
HU906268D0 (en) 1991-03-28
JP2899577B2 (ja) 1999-06-02
JPS6471894A (en) 1989-03-16
DE3856477D1 (de) 2001-07-19
JPH1072484A (ja) 1998-03-17
DE3856330T2 (de) 1999-09-30
DE3856527D1 (de) 2002-06-06
IL87517A0 (en) 1989-01-31
EP0306190A2 (en) 1989-03-08
DE3856477T2 (de) 2001-11-08
JP2777359B2 (ja) 1998-07-16
JPH1072483A (ja) 1998-03-17
HU206886B (en) 1993-01-28
ATE217009T1 (de) 2002-05-15
JPH1072457A (ja) 1998-03-17
ES2157289T3 (es) 2001-08-16
EP0688782B1 (en) 2002-05-02
DE3856527T2 (de) 2002-10-31
EP0688783A1 (en) 1995-12-27
EP0306190A3 (en) 1991-11-21
ATE179713T1 (de) 1999-05-15

Similar Documents

Publication Publication Date Title
ES2113845T3 (es) Procedimiento de preparacion de intermediarios utiles en la preparacion de 2',2'-difluoronucleosidos.
MY103514A (en) Process for production of a avermectins and cultures therefor.
IE880159L (en) Process for production of avermectins and cultures therefor
FR2541305B1 (fr) Procede de production d'une preparation d'enzyme immobilisee, preparation d'enzyme immobilisee obtenue et utilisation de celle-ci
DE3586017D1 (de) Stabiles glukose-isomerase-konzentrat und verfahren zu dessen herstellung.
FI884250L (fi) Menetelmä suurien levymäisten, neulamaisten kipsikiteiden valmistamiseksi
IT1261230B (it) Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione.
DE3855002D1 (de) Verfahren zur Herstellung von Dodecahydro-3a,6,6,9a-tetramethylnaphto(2,1-b)furan
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
ATE34176T1 (de) 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
EP0313297A3 (en) Process for production of avermectin aglycones and cultures therefor
FR2564093B1 (fr) Procede pour la preparation d'adenosine3', 5'-monophosphate cyclique n6-substitue ou des sels correspondants
GB2193204B (en) Method of producing ceramic composition
SU1593572A3 (ru) Cпocoб пoлучehия tиoфehobыx coeдиhehий или иx opгahичeckиx coлeй
UA3421C1 (uk) Спосіб одержання похідних 2-тіазолідінону
IT1206247B (it) Metodo e composizione per migliorare il regime di crescita di animali
ATE107631T1 (de) Verfahren zur herstellung von indolinon-2- derivaten.
ES500197A0 (es) Procedimiento para la preparacion de derivados de oligorri- bosido de acido homocitrico
HUT48614A (en) Process for producing desmalonyl derivatives of macrolide lactones
HU902500D0 (en) Process for producing intermediaries of n,n'-diacyl-aminales
PT80351A (en) Process for preparing fenoldopam 4',8-bis-hydrogen sulfates
DE3583794D1 (de) Verfahren zur herstellung von bestaendigen pharmazeutischen zusammensetzungen von prostaglandin-e-derivaten und/oder ihren 15r-formen.
DE69225610D1 (de) Verfahren zur herstellung von avermectin und kulturen dafür
KR870007944A (ko) 뉴클레오시드류의 제조 방법
PL265216A1 (en) Method of obtaining 1,4:3,6-dianhydro-d-sorbite 2,5-dinitrate

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 306190

Country of ref document: ES